24/03/2026
🎉**Alhamdulillah! New Publication** 🎉
https://dx.doi.org/10.51244/IJRSI.2026.130200144
I am delighted to share that our review article titled:
**“Precision Medicine in Type 2 Diabetes Mellitus: Advances in Continuous Assessment, Subclassification, Personalized Therapies, and Disease Remission”**
has been successfully published in the **International Journal of Research and Scientific Innovation (IJRSI)** (February 2026 issue).
👨⚕️ **Authors:**
Dr. Mohammad Ali Asraf Suhag
Dr. Sumon Ray Chowdhury
Dr. Sufi Sumsul Yeaman
🔬 **What this paper covers:**
✔️ Role of Continuous Glucose Monitoring (CGM) in modern diabetes care
✔️ Subclassification of Type 2 Diabetes (SIRD, SIDD, etc.)
✔️ Personalized treatment strategies (SGLT2i, GLP-1 RA, pharmacogenomics)
✔️ Emerging concepts like AI, multi-omics & digital health
✔️ Possibility of diabetes remission through lifestyle and advanced interventions
This work highlights how diabetes management is shifting from a “one-size-fits-all” approach to truly **personalized, precision-based care** opening new doors for better outcomes and even disease reversal in selected patients.
📖 Grateful to Authors, mentors, and everyone who supported this work.
Precision Medicine in Type 2 Diabetes Mellitus: Advances in Continuous Assessment, Subclassification, Personalized Therapies, and Disease Remission: A Comprehensive Review. Precision medicine in type 2 diabetes mellitus (T2DM) shifts from uniform treatment to individualized strategies addressing genetic, metabolic, environmental, and clinical heterogeneity. Key pillars i
18/03/2026
17/03/2026
24/02/2026
27/01/2026
20/01/2026
16/01/2026